Manju Deshbandhu Gupta

Manju Deshbandhu Gupta

Active Director Director DIN 00209461 India's Richest · #55
DIN 00209461 First appointment Feb 1976 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 14 historical roles
Total affiliations 19 Since Feb 1976
Shareholding value •••• Premium profile

About Manju Deshbandhu Gupta

Data last updated:

Manju Deshbandhu Gupta is a Director at Lupin Limited (since 2014), Director at Lupin Manufacturing Solutions Limited (since 2025) and Director at Polynova Industries Limited (since 2024), and holds 2 more current directorships. The companies operate in Pharma, Manufacturing and Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹29,502 Cr; the largest is Lupin Limited at ₹28,382 Cr (FY 2026). Earlier, Manju Deshbandhu Gupta was a Director at Lupin Investments Private Limited (1984–2023) and Director at Visiomed Investments Private Limited (2022–2023) and 12 more.

Manju D Gupta and family are #55 among India's richest people (2026), with wealth of ₹50,000 Cr.

DIN 00209461
Primary Designation Director
Industry Pharma
First Appointment 16 Feb 1976
Oldest Company Age 55 yrs
Largest company Lupin Limited · ₹28,382 Cr (FY 2026)
Combined revenue ₹29,502 Cr across 5 companies

Recognitions & Rankings

India's Richest People 2026 edition · Source: Hurun India
Rank#55
Wealth
₹50,000 Cr
Company
Lupin
2025 #55 2023 #76 2021 #71
India's Top Philanthropists 2022 edition · Source: Hurun India
Rank#47
Donation
₹16 Cr
Main cause
Rural Development
2021 #50 2020 #32

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lupin Limited L24100MH1983PLC029442
Director01 Apr 20141983₹28,382 Cr (FY 2026)Active
Director28 Mar 20252023₹435 Cr (FY 2025)Active
Polynova Industries Limited U25209MH1986PLC041294
Director30 Sep 20241986₹329 Cr (FY 2025)Active
Lupin Life Sciences Limited U86100MH2023PLC406793
Director30 Jun 20262023₹257 Cr (FY 2025)Active
Lupin Diagnostics Limited U24100MH2011PLC214885
Director12 May 20222011₹98.57 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lupin Investments Private Limited U65990MH1984PTC034012
Director13 Sep 19841984₹376 Cr (FY 2025)Active
Visiomed Investments Private Limited U65999MH2022PTC376686
Director12 Feb 20222022Active
Synchem Properties Private Limited U70102MH2015PTC269591
Director26 Oct 20152015₹4.76 Cr (FY 2025)Active
Zyma Properties Private Limited U70109MH2017PTC291325
Additional Director05 Apr 20172017₹9.77 Cr (FY 2025)Active
Lupin International Private Limited U24110MH1988PTC046677
Director28 Aug 19901988Amalgamated
Synchem Investments Private Limited U24110MH1991PTC063012
Director15 Mar 20131991Amalgamated
Director07 Nov 20171995Dissolved (Liquidated)
Zyma Laboratories Limited U24230MH1970PLC014881
Director16 Feb 19761970₹113 Cr (FY 2016)Amalgamated
Novamed Investments Private Limited U24232MH1988PTC271202
Director15 Mar 20131988₹60.9 Lakh (FY 2016)Amalgamated
Visiomed Investments Private Limited U33202MH1989PTC052278
Director19 Jan 20051989₹68.20 Cr (FY 2016)Amalgamated
Lupin Holdings Private Limited U51900MH1988PTC046185
Director19 Jan 20051988₹32.93 Cr (FY 2016)Amalgamated
Rahas Investments Private Limited U65990MH1991PTC060087
Director01 Dec 19911991₹34.51 Cr (FY 2016)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Manju Deshbandhu Gupta

Directorship timeline

Open interactive timeline →
Lupin Limited
Lupin Manufacturing Solutions Limited
Lupin Diagnostics Limited
Lupin International Private Limited
Premium access

Shareholding and investment profile for Manju Deshbandhu Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manju Deshbandhu Gupta

Manju Deshbandhu Gupta currently holds 5 directorships: Lupin Limited (Director, since 01 Apr 2014, revenue ₹28,382 Cr (FY 2026)); Lupin Manufacturing Solutions Limited (Director, since 28 Mar 2025, revenue ₹435 Cr (FY 2025)); Polynova Industries Limited (Director, since 30 Sep 2024, revenue ₹329 Cr (FY 2025)); Lupin Life Sciences Limited (Director, since 30 Jun 2026, revenue ₹257 Cr (FY 2025)); Lupin Diagnostics Limited (Director, since 12 May 2022, revenue ₹98.57 Cr (FY 2025)).

Manju Deshbandhu Gupta was first appointed on 16 Feb 1976 as Director at Zyma Laboratories Limited. The most recent appointment on record is 30 Jun 2026 at Lupin Life Sciences Limited.

The 5 current companies of Manju Deshbandhu Gupta that report revenue have a combined latest revenue of ₹29,502 Cr: Lupin Limited ₹28,382 Cr (FY 2026); Lupin Manufacturing Solutions Limited ₹435 Cr (FY 2025); Polynova Industries Limited ₹329 Cr (FY 2025); Lupin Life Sciences Limited ₹257 Cr (FY 2025); Lupin Diagnostics Limited ₹98.57 Cr (FY 2025).

Manju Deshbandhu Gupta held 14 earlier board appointments: Lupin Investments Private Limited (Director, 13 Sep 1984 to 29 Apr 2023); Visiomed Investments Private Limited (Director, 12 Feb 2022 to 09 May 2023); Synchem Properties Private Limited (Director, 26 Oct 2015 to 09 May 2023); Zyma Properties Private Limited (Additional Director, 05 Apr 2017 to 28 Sep 2018); Lupin International Private Limited (Director, from 28 Aug 1990); and 9 more.

The current boards of Manju Deshbandhu Gupta's companies include Alfonso Martin Gimenez Zulueta (Lupin Limited), Amit Kumar Gupta (Lupin Limited), Anand Kripalu (Lupin Limited), Jeffrey Bruce Kindler (Lupin Limited), Kanwar Bir Singh Anand (Lupin Limited), Mark Daniel Mc Dade (Lupin Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available